Operating Income Summary of PharmaEngine, Inc.

PharmaEngine, Inc.'s latest annual operating income in 2023 was 277.18 Million TWD , down -29.39% from previous year.
PharmaEngine, Inc.'s latest quarterly operating income in 2024 Q2 was 143.68 Million TWD , up 39.76% from previous quarter.
PharmaEngine, Inc. reported an annual operating income of 392.54 Million TWD in 2022, down -28.02% from previous year.
PharmaEngine, Inc. reported an annual operating income of 545.39 Million TWD in 2021, down -27.56% from previous year.
PharmaEngine, Inc. reported a quarterly operating income of 102.81 Million TWD for 2024 Q1, up 57.77% from previous quarter.
PharmaEngine, Inc. reported a quarterly operating income of 103.13 Million TWD for 2023 Q3, up 42.66% from previous quarter.

Annual Operating Income Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Operating Income of PharmaEngine, Inc. (2023 - 2009)

Year	Operating Income	Operating Income Growth
2023	277.18 Million TWD	-29.39%
2022	392.54 Million TWD	-28.02%
2021	545.39 Million TWD	-27.56%
2020	752.91 Million TWD	1412.52%
2019	49.77 Million TWD	17.29%
2018	42.44 Million TWD	-93.08%
2017	612.97 Million TWD	-24.15%
2016	808.12 Million TWD	146.89%
2015	327.32 Million TWD	363.98%
2014	70.54 Million TWD	150.58%
2013	-139.48 Million TWD	-381.04%
2012	49.63 Million TWD	-79.52%
2011	242.31 Million TWD	363.51%
2010	-91.95 Million TWD	13.45%
2009	-106.24 Million TWD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	143.68 Million TWD	39.76%
2024 Q1	102.81 Million TWD	57.77%
2023 Q3	103.13 Million TWD	42.66%
2023 Q4	65.16 Million TWD	-36.82%
2023 FY	277.18 Million TWD	-29.39%
2023 Q1	102.54 Million TWD	59.26%
2023 Q2	72.29 Million TWD	-29.5%
2022 Q1	122.15 Million TWD	-12.3%
2022 Q2	104.29 Million TWD	-14.62%
2022 Q3	101.71 Million TWD	-2.47%
2022 Q4	64.38 Million TWD	-36.7%
2022 FY	392.54 Million TWD	-28.02%
2021 Q1	34.34 Million TWD	-95.11%
2021 Q2	94.14 Million TWD	174.09%
2021 Q3	98.76 Million TWD	4.91%
2021 Q4	139.29 Million TWD	41.03%
2021 FY	545.39 Million TWD	-27.56%
2020 Q3	40.62 Million TWD	13.76%
2020 Q2	35.71 Million TWD	13.23%
2020 FY	752.91 Million TWD	1412.52%
2020 Q1	31.54 Million TWD	284.33%
2020 Q4	701.81 Million TWD	1627.38%
2019 Q3	12.97 Million TWD	1911.78%
2019 FY	49.77 Million TWD	17.29%
2019 Q4	8.2 Million TWD	-36.75%
2019 Q2	645 Thousand TWD	-94.02%
2019 Q1	10.78 Million TWD	-12.95%
2018 Q2	-10.8 Million TWD	62.87%
2018 Q3	69.97 Million TWD	747.38%
2018 FY	42.44 Million TWD	-93.08%
2018 Q4	12.38 Million TWD	-82.3%
2018 Q1	-29.11 Million TWD	-104.26%
2017 Q1	-36.88 Million TWD	-105.42%
2017 Q3	-4.99 Million TWD	82.75%
2017 Q2	-28.96 Million TWD	21.48%
2017 Q4	683.82 Million TWD	13787.35%
2017 FY	612.97 Million TWD	-24.15%
2016 FY	808.12 Million TWD	146.89%
2016 Q4	680.03 Million TWD	968.62%
2016 Q3	-78.28 Million TWD	-132.63%
2016 Q2	239.95 Million TWD	814.69%
2016 Q1	-33.57 Million TWD	27.46%
2015 FY	327.32 Million TWD	363.98%
2015 Q4	-46.28 Million TWD	-23.69%
2015 Q3	-37.41 Million TWD	-108.49%
2015 Q2	440.9 Million TWD	1575.54%
2015 Q1	-29.88 Million TWD	52.42%
2014 Q3	180.12 Million TWD	752.45%
2014 Q2	-27.6 Million TWD	-44.06%
2014 Q1	-19.16 Million TWD	36.21%
2014 FY	70.54 Million TWD	150.58%
2014 Q4	-62.8 Million TWD	-134.87%
2013 Q3	-69.32 Million TWD	-228.61%
2013 Q1	-19.02 Million TWD	-10.88%
2013 Q2	-21.09 Million TWD	-10.91%
2013 Q4	-30.04 Million TWD	56.66%
2013 FY	-139.48 Million TWD	-381.04%
2012 Q3	-60.54 Million TWD	-393.29%
2012 Q4	-17.15 Million TWD	71.67%
2012 Q2	-12.27 Million TWD	-108.8%
2012 FY	49.63 Million TWD	-79.52%
2012 Q1	139.55 Million TWD	3747.46%
2011 Q2	266.69 Million TWD	1441.31%
2011 FY	242.31 Million TWD	363.51%
2011 Q4	-3.82 Million TWD	-475.34%
2011 Q1	-19.88 Million TWD	0.0%
2011 Q3	-665 Thousand TWD	-100.25%
2010 FY	-91.95 Million TWD	13.45%
2009 FY	-106.24 Million TWD	0.0%

Peer Operating Income Comparison of PharmaEngine, Inc.

Name	Operating Income	Operating Income Difference
GeneReach Biotechnology Corp.	-229.28 Million TWD	220.89%
Sunmax Biotechnology Co., Ltd.	894.79 Million TWD	69.023%
Lukas Biomedical Inc.	-43.56 Million TWD	736.325%
SYN-TECH Chem. & Pharm. Co., Ltd.	281.85 Million TWD	1.656%
Level Biotechnology Inc.	67.55 Million TWD	-310.325%
Sagittarius Life Science Corp	-64.37 Million TWD	530.569%
NeoCore Technology Co., Ltd.	-84.94 Million TWD	426.313%
TaiMed Biologics Inc.	-166.23 Million TWD	266.746%
GlycoNex Incorporation	-259.86 Million TWD	206.665%
VBI	-16.13 Million TWD	1818.218%
Taiwan Advance Bio-Pharmaceutical Inc.	-2.25 Million TWD	12402.841%
SynCore Biotechnology Co.,Ltd	-45.5 Million TWD	709.167%
Genomics BioSci & Tech. Co.,Ltd.	-84.99 Million TWD	426.121%
Visgeneer Inc.	-21.15 Million TWD	1410.0%
Mycenax Biotech Inc.	-602.1 Million TWD	146.036%
G&E Herbal Biotechnology Co., Ltd.	80.68 Million TWD	-243.541%
Neith Corporation	-48.85 Million TWD	667.37%
TaiwanJ Pharmaceuticals Co., Ltd.	-6.61 Million TWD	4293.389%
Enimmune corporation	-243.47 Million TWD	213.845%
TaiRx, Inc.	-214.69 Million TWD	229.105%
CHO Pharma, Inc.	-268.99 Million TWD	203.043%
EirGenix Inc.	-1.03 Billion TWD	126.859%
BioLASCO Taiwan Co., Ltd.	63.33 Million TWD	-337.646%
Sunny Pharmtech Inc.	-72.09 Million TWD	484.464%
Advagene Biopharma Co., Ltd.	-93.33 Million TWD	396.973%
BioGend Therapeutics Co., Ltd.	-176.54 Million TWD	257.008%
Feng Chi Biotech Corp.	24.16 Million TWD	-1047.186%
RBC Bioscience Corporation	14.53 Million TWD	-1806.479%
BiOptic Inc.	44.05 Million TWD	-529.203%
Anti-Microbial Savior BioteQ Co., Ltd	-56.74 Million TWD	588.437%
BRIM Biotechnology, Inc.	-694.12 Million TWD	139.933%
Shine-On BioMedical Co.,Ltd.	-62.68 Million TWD	542.198%
Great Novel Therapeutics Biotech & Medicals	-65.81 Million TWD	521.123%
Syngen Biotech Co.,Ltd.	334.08 Million TWD	17.031%
Medigen Vaccine Biologics Corporation	-1.21 Billion TWD	122.835%
Bio Preventive Medicine Corp.	-70.58 Million TWD	492.711%
Lin BioScience, Inc.	-1.09 Billion TWD	125.271%
NaviFUS Corp.	-76.42 Million TWD	462.682%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	-93.95 Million TWD	395.017%
Sinew Pharma Inc.	-186.25 Million TWD	248.821%
Andros Pharmaceuticals Co.,Ltd	-67.69 Million TWD	509.447%
Greenyn Biotechnology Co., Ltd	159.81 Million TWD	-73.438%
Lumosa Therapeutics Co., Ltd.	-375.62 Million TWD	173.792%
AP Biosciences Inc	-347.47 Million TWD	179.77%
Medigen Biotechnology Corp.	-1.23 Billion TWD	122.479%
3D Global Biotech Inc.	-62.85 Million TWD	541.002%
Pharmosa Biopharm Inc.	-2.82 Million TWD	9915.262%
Intech Biopharm Corporation	-304.39 Million TWD	191.06%
Oneness Biotech Co., Ltd.	-1.09 Billion TWD	125.276%
Eusol Biotech Co.,Ltd.	-41.48 Million TWD	768.201%
TWi Biotechnology, Inc.	-169.55 Million TWD	263.476%
Ever Supreme Bio Technology Co., Ltd	337.73 Million TWD	17.928%
TCI GENE Inc.	10.04 Million TWD	-2658.314%
MegaPro Biomedical Co., Ltd	-127.25 Million TWD	317.814%
Senhwa Biosciences, Inc.	-311.11 Million TWD	189.095%
Taiwan Bio Therapeutics Co., Ltd	-212.2 Million TWD	230.621%
NatureWise Biotech & Medicals Corporation	3.43 Million TWD	-7971.724%
Savior Lifetec Corporation	-2.42 Million TWD	11553.843%
TaiGen Biopharmaceuticals Holdings Limited	-174.69 Million TWD	258.663%
OBI Pharma, Inc.	-2.08 Billion TWD	113.264%
Meribank Biotech Co., Ltd	-123.15 Million TWD	325.07%
Acepodia, Inc.	-435.97 Million TWD	163.578%
Caliway Biopharmaceuticals Co., Ltd.	-487.95 Million TWD	156.805%

Global Stocks Search

PharmaEngine, Inc. (4162.TWO)

Operating Income Summary of PharmaEngine, Inc.

Annual Operating Income Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Operating Income of PharmaEngine, Inc. (2023 - 2009)

Peer Operating Income Comparison of PharmaEngine, Inc.